(Q34558806)

3 August 2017

0 references

1 reference

title

Acellular pertussis vaccine safety and efficacy in children, adolescents and adults (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Janet R Casey

1

1 reference

3 August 2017

Michael E Pichichero

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2005

1 reference

3 August 2017

1 reference

3 August 2017

volume

65

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

1367-1389

1 reference

Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP--T-HBs) administered at 2, 4, 6 and 12-14 months of age.

3 August 2017

cites work

1 reference

12 December 2020

Comparison of antibody titers in eleven- to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids

1 reference

12 December 2020

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

1 reference

12 December 2020

Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants

1 reference

12 December 2020

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

1 reference

12 December 2020

Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants.

1 reference

12 December 2020

Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at

1 reference

12 December 2020

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

1 reference

12 December 2020

Return of epidemic pertussis in the United States

1 reference

12 December 2020

1 reference

12 December 2020

Adult immunization with acellular pertussis vaccine

1 reference

12 December 2020

The changing age and seasonal profile of pertussis in Canada

1 reference

12 December 2020

Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons

1 reference

12 December 2020

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997

1 reference

12 December 2020

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group

1 reference

12 December 2020

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccin

1 reference

12 December 2020

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine

1 reference

12 December 2020

Randomised controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at two, three and four months of age.

1 reference

12 December 2020

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

12 December 2020

Pertussis--United States, 1997-2000.

1 reference

12 December 2020

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

1 reference

12 December 2020

Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

1 reference

12 December 2020

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

12 December 2020

Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.

1 reference

12 December 2020

Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection

1 reference

12 December 2020

Crucial role of antibodies to pertactin in Bordetella pertussis immunity

1 reference

12 December 2020

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

1 reference

12 December 2020

Cell‐Mediated Immunity and Antibody Responses toBordetella pertussisAntigens in Children with a History of Pertussis Infection and in Recipients of an Acellular Pertussis Vaccine

1 reference

12 December 2020

Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model

1 reference

12 December 2020

Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults

1 reference

12 December 2020

Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines

1 reference

12 December 2020

The acellular pertussis vaccine trials: an interpretation

1 reference

12 December 2020

Impact of Haemophilus influenzae Type b Polysaccharide-Tetanus Protein Conjugate Vaccine on Responses to Concurrently Administered Diphtheria-Tetanus-Pertussis Vaccine

1 reference

12 December 2020

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

12 December 2020

Safety and immunogenicity of acellular diphtheria-tetanus-pertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites

1 reference

12 December 2020

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age

1 reference

12 December 2020

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

1 reference

12 December 2020

Immunoglobulin A-mediated protection against Bordetella pertussis infection

1 reference

12 December 2020

Identification of human T-cell epitopes on the S4 subunit of pertussis toxin

1 reference

12 December 2020

An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine

1 reference

12 December 2020

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

1 reference

12 December 2020

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

12 December 2020

Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy

1 reference

12 December 2020

A placebo-controlled trial of a pertussis-toxoid vaccine

1 reference

12 December 2020

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

1 reference

12 December 2020

National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, April 1994-March 1995.

1 reference

12 December 2020

The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans

1 reference

12 December 2020

A comparative study of PENTA™ vaccine booster doses given at 12, 15 or 18 months of age

1 reference

12 December 2020

EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN

1 reference

12 December 2020

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

12 December 2020

VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Lee

1 reference

12 December 2020

Evaluation of pertussis in U.S. Marine Corps trainees

1 reference

12 December 2020

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

1 reference

12 December 2020

Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis

1 reference

12 December 2020

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

12 December 2020

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children

1 reference

12 December 2020

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials

1 reference

12 December 2020

Pertussis resurgence in Canada largely caused by a cohort effect.

1 reference

12 December 2020

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

1 reference

12 December 2020

Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants

1 reference

12 December 2020

Effectiveness of vaccination for Haemophilus influenzae type b

1 reference

12 December 2020

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

12 December 2020

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

1 reference

12 December 2020

Economic impact of pertussis

1 reference

12 December 2020

A search for Bordetella pertussis infection in university students

1 reference

12 December 2020

A mucosal antibody response following systemic Haemophilus influenzae type B infection in children

1 reference

12 December 2020

The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants

1 reference

12 December 2020

The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine

1 reference

12 December 2020

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules. Multicenter Working Group

1 reference

12 December 2020

Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines

1 reference

12 December 2020

Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection

1 reference

12 December 2020

Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age.

1 reference

12 December 2020

Severe local reactions to pneumococcal vaccine

1 reference

12 December 2020

Efficacy of acellular pertussis vaccine in early childhood after household exposure.

1 reference

12 December 2020

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

1 reference

12 December 2020

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

12 December 2020

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two

1 reference

12 December 2020

A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults

1 reference

12 December 2020

The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial

1 reference

12 December 2020

Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants.

1 reference

12 December 2020

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

1 reference

12 December 2020

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

1 reference

12 December 2020

VACCINATION against whooping-cough; the final report to the Whooping-Cough Immunization Committee of the Medical Research Council and to the medical officers of health for Battersea and Wandsworth, Bradford, Liverpool, and Newcastle

1 reference

12 December 2020

Field Evaluation of a Human Anthrax Vaccine

1 reference

12 December 2020

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System

1 reference

12 December 2020

Efficacy of a two-component acellular pertussis vaccine in infants

1 reference

12 December 2020

Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine or as pentavalent vaccine

1 reference

12 December 2020

Comparison of acellular pertussis-diphtheria-tetanus toxoids and Haemophilus influenzae type b vaccines administered separately vs. combined in younger vs. older toddlers

1 reference

12 December 2020

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

1 reference

12 December 2020

Outbreak of pertussis in a fully immunized adolescent and adult population

1 reference

12 December 2020

Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)

1 reference

12 December 2020

Household contact study of Bordetella pertussis infections

1 reference

12 December 2020

The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six mont

1 reference

12 December 2020

Immunogenicity and reactogenicity of the Biken acellular pertussis vaccine in young adults

1 reference

12 December 2020

Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood

1 reference

12 December 2020

Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents

1 reference

12 December 2020

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

1 reference

12 December 2020

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

1 reference

12 December 2020

No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe

1 reference

12 December 2020

Efficacy and safety of acellular pertussis vaccine in Aichi Prefecture, Japan

1 reference

12 December 2020

Pertussis Outbreaks in Groups Claiming Religious Exemptions to Vaccinations

1 reference

12 December 2020

Epidemiological features of pertussis in the United States, 1980-1989.

1 reference

12 December 2020

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four

1 reference

12 December 2020

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

12 December 2020

Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids

1 reference

12 December 2020

International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine.

1 reference

12 December 2020

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

1 reference

12 December 2020

Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine.

1 reference

12 December 2020

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness

1 reference

12 December 2020

Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses

1 reference

12 December 2020

Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants

1 reference

12 December 2020

Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation

1 reference

12 December 2020

Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation

1 reference

12 December 2020

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

12 December 2020

Systematic review of the effects of pertussis vaccines in children.

1 reference

12 December 2020

Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine

1 reference

12 December 2020

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents

1 reference

12 December 2020

Analysis of Haemophilus influenzae type B conjugate and diphtheria-tetanus-pertussis combination vaccines

1 reference

12 December 2020

Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants.

1 reference

12 December 2020

Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States

1 reference

12 December 2020

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

12 December 2020

Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers

1 reference

12 December 2020

Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine.

1 reference

12 December 2020

Costs of illness due to Bordetella pertussis in families

1 reference

12 December 2020

Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine

1 reference

12 December 2020

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group

1 reference

12 December 2020

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants

1 reference

12 December 2020

Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization

1 reference

12 December 2020

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age

1 reference

12 December 2020

Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults

1 reference

12 December 2020

Intrafamilial spread of pertussis

1 reference

12 December 2020

Food and Drug Administration approval of use of Haemophilus influenzae type b conjugate vaccine reconstituted with diphtheria-tetanus-pertussis vaccine for infants and children

1 reference

12 December 2020

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

1 reference

12 December 2020

A pertussis outbreak in a Wisconsin nursing home.

1 reference

12 December 2020

FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children

1 reference

12 December 2020

Dissecting human T cell responses against Bordetella species

1 reference

12 December 2020

Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations

1 reference

12 December 2020

Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists

1 reference

12 December 2020

Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile

1 reference

12 December 2020

Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology

1 reference

12 December 2020

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

1 reference

12 December 2020

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization

1 reference

12 December 2020

Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism

1 reference

12 December 2020

Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination

1 reference

12 December 2020

Unrecognized pertussis infection in adolescents.

1 reference

12 December 2020

Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions

1 reference

12 December 2020

Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines

1 reference

12 December 2020

Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?

1 reference

12 December 2020

Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid

1 reference

12 December 2020

Immunogenicity and safety of a liquid combination of DTP-PRP-T [corrected] vs lyophilized PRP-T reconstituted with DTP

1 reference

12 December 2020

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

1 reference

12 December 2020

Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune responses with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as m

1 reference

12 December 2020

10.2165/00003495-200565100-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1004565810

0 references

1 reference